Literature DB >> 28017355

Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.

Carolyn S P Lam1, Michiel Rienstra2, Wan Ting Tay3, Licette C Y Liu2, Yoran M Hummel2, Peter van der Meer2, Rudolf A de Boer2, Isabelle C Van Gelder2, Dirk J van Veldhuisen2, Adriaan A Voors4, Elke S Hoendermis2.   

Abstract

OBJECTIVES: This study sought to study the association of atrial fibrillation (AF) with exercise capacity, left ventricular filling pressure, natriuretic peptides, and left atrial size in heart failure with preserved ejection fraction (HFpEF).
BACKGROUND: The diagnosis of HFpEF in patients with AF remains a challenge because both contribute to impaired exercise capacity, and increased natriuretic peptides and left atrial volume.
METHODS: We studied 94 patients with symptomatic heart failure and left ventricular ejection fractions ≥45% using treadmill cardiopulmonary exercise testing and right- and/or left-sided cardiac catheterization with simultaneous echocardiography.
RESULTS: During catheterization, 62 patients were in sinus rhythm, and 32 patients had AF. There were no significant differences in age, sex, body size, comorbidities, or medications between groups; however, patients with AF had lower peak oxygen consumption (VO2) compared with those with sinus rhythm (10.8 ± 3.1 ml/min/kg vs. 13.5 ± 3.8 ml/min/kg; p = 0.002). Median (25th to 75th percentile) N-terminal pro-B-type natriuretic peptide (NT-proBNP) was higher in AF versus sinus rhythm (1,689; 851 to 2,637 pg/ml vs. 490; 272 to 1,019 pg/ml; p < 0.0001). Left atrial volume index (LAVI) was higher in AF than sinus rhythm (57.8 ± 17.0 ml/m2 vs. 42.5 ± 15.1 ml/m2; p = 0.001). Invasive hemodynamics showed higher mean pulmonary capillary wedge pressure (PCWP) (19.9 ± 3.7 vs. 15.2 ± 6.8) in AF versus sinus rhythm (all p < 0.001), with a trend toward higher left ventricular end-diastolic pressure (17.7 ± 3.0 mm Hg vs. 15.7 ± 6.9 mm Hg; p = 0.06). After adjusting for clinical covariates and mean PCWP, AF remained associated with reduced peak VO2 increased log NT-proBNP, and enlarged LAVI (all p ≤0.005).
CONCLUSIONS: AF is independently associated with greater exertional intolerance, natriuretic peptide elevation, and left atrial remodeling in HFpEF. These data support the application of different thresholds of NT-proBNP and LAVI for the diagnosis of HFpEF in the presence of AF versus the absence of AF.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; heart failure with preserved ejection fraction; left atrial volume; left ventricular filling pressures; natriuretic peptides

Mesh:

Substances:

Year:  2016        PMID: 28017355     DOI: 10.1016/j.jchf.2016.10.005

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  46 in total

1.  A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Rickey E Carter; Masaru Obokata; Margaret M Redfield; Barry A Borlaug
Journal:  Circulation       Date:  2018-08-28       Impact factor: 29.690

Review 2.  Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions.

Authors:  Bharathi Upadhya; Dalane W Kitzman
Journal:  Am J Cardiovasc Drugs       Date:  2017-08       Impact factor: 3.571

Review 3.  The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging?

Authors:  Masaru Obokata; Yogesh N V Reddy; Barry A Borlaug
Journal:  Heart Fail Clin       Date:  2019-02-02       Impact factor: 3.179

4.  Left atrial dysfunction: the next key target in heart failure with preserved ejection fraction.

Authors:  Masaru Obokata; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2019-02-08       Impact factor: 15.534

Review 5.  Evolution of a Geriatric Syndrome: Pathophysiology and Treatment of Heart Failure with Preserved Ejection Fraction.

Authors:  Bharathi Upadhya; Barbara Pisani; Dalane W Kitzman
Journal:  J Am Geriatr Soc       Date:  2017-11       Impact factor: 5.562

Review 6.  Addressing Comorbidities in Heart Failure: Hypertension, Atrial Fibrillation, and Diabetes.

Authors:  Aakash Bavishi; Ravi B Patel
Journal:  Heart Fail Clin       Date:  2020-07-21       Impact factor: 3.179

Review 7.  Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions.

Authors:  Bharathi Upadhya; Mark J Haykowsky; Dalane W Kitzman
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 8.  Cardiac aging and heart disease in humans.

Authors:  Marja Steenman; Gilles Lande
Journal:  Biophys Rev       Date:  2017-03-20

Review 9.  Heart Failure With Preserved Ejection Fraction: A Perioperative Review.

Authors:  Sasha K Shillcutt; M Megan Chacon; Tara R Brakke; Ellen K Roberts; Thomas E Schulte; Nicholas Markin
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-08-30       Impact factor: 2.628

10.  Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021.

Authors:  Fabiana G Marcondes-Braga; Lídia Ana Zytynski Moura; Victor Sarli Issa; Jefferson Luis Vieira; Luis Eduardo Rohde; Marcus Vinícius Simões; Miguel Morita Fernandes-Silva; Salvador Rassi; Silvia Marinho Martins Alves; Denilson Campos de Albuquerque; Dirceu Rodrigues de Almeida; Edimar Alcides Bocchi; Felix José Alvarez Ramires; Fernando Bacal; João Manoel Rossi Neto; Luiz Claudio Danzmann; Marcelo Westerlund Montera; Mucio Tavares de Oliveira Junior; Nadine Clausell; Odilson Marcos Silvestre; Reinaldo Bulgarelli Bestetti; Sabrina Bernadez-Pereira; Aguinaldo F Freitas; Andréia Biolo; Antonio Carlos Pereira Barretto; Antônio José Lagoeiro Jorge; Bruno Biselli; Carlos Eduardo Lucena Montenegro; Edval Gomes Dos Santos Júnior; Estêvão Lanna Figueiredo; Fábio Fernandes; Fabio Serra Silveira; Fernando Antibas Atik; Flávio de Souza Brito; Germano Emílio Conceição Souza; Gustavo Calado de Aguiar Ribeiro; Humberto Villacorta; João David de Souza Neto; Livia Adams Goldraich; Luís Beck-da-Silva; Manoel Fernandes Canesin; Marcelo Imbroinise Bittencourt; Marcely Gimenes Bonatto; Maria da Consolação Vieira Moreira; Mônica Samuel Avila; Otavio Rizzi Coelho Filho; Pedro Vellosa Schwartzmann; Ricardo Mourilhe-Rocha; Sandrigo Mangini; Silvia Moreira Ayub Ferreira; José Albuquerque de Figueiredo Neto; Evandro Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2021-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.